PD Dr. Manuela Krumbholz

Department of Paediatrics and Adolescent Medicine

Blocking counter regulation of unfolded protein response by targeted protein synthesis inhibition produces highly synergistic cell death in several cancer entities (2020) Müller F, Gsottberger F, Meier C, Petkovic S, Krumbholz M, Metzler M, Mackensen A Conference contribution Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma (2020) Lin SH, Sampson JN, Grünewald TG, Surdez D, Reynaud S, Mirabeau O, Karlins E, et al. Journal article Sarcoma treatment in the era of molecular medicine (2020) Grünewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F, Di Pompo G, et al. Journal article, Review article Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA (European Journal of Nuclear Medicine and Molecular Imaging, (2019), 10.1007/s00259-019-04649-1) (2020) Schmidkonz C, Krumbholz M, Atzinger A, Cordes M, Götz T, Prante O, Ritt P, et al. Journal article, Erratum Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer (2019) Krumbholz M, Agaimy A, Stöhr R, Burger M, Wach S, Taubert H, Wullich B, et al. Journal article Large amplicon droplet digital PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia (2019) Krumbholz M, Görlitz K, Albert C, Lawlor J, Suttorp M, Metzler M Journal article 2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts (2019) Wagner F, Meier C, Krumbholz M, Metzler M, Mackensen A, Müller F Conference contribution Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA (2019) Schmidkonz C, Krumbholz M, Atzinger A, Cordes M, Goetz TI, Prante O, Ritt P, et al. Journal article High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia (2019) Hoffmann J, Krumbholz M, Gutiérrez HP, Fillies M, Szymansky A, Bleckmann K, zur Stadt U, et al. Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article